This three-day international symposium hosted by the NCI RAS Initiative brings together RAS and cancer researchers from across the globe to hear from featured invited presentations, short presentations from selected abstracts, and poster presentations. This event is held in person in Frederick, Maryland with virtual components.

Almost a third of all human cancers, including 95 percent of pancreatic cancers, are driven by mutated RAS genes. The symposium strives to engage researchers, fostering potential collaborations and bring in new thought leaders.

The RAS Symposium happens about every other year. The Fifth RAS Initiative Symposium is scheduled for October 2024.

Join us for three days of engaging presentations from top scientific leaders in the RAS field and short talks showcasing selected abstracts, participate in two dynamic poster sessions, and meet and interact with experts in the field. This event promises to provide a highly interactive forum for sharing the latest advancements and insights in RAS research. Additionally, don't miss our networking event—an opportunity to reconnect with old friends and forge new connections.

To get an idea of the agenda, review the Fourth RAS Initiative Symposium 2022.

Related Content

Structural image of RAS-RAF

RAS Initiative

Learn more

Past Events

Margaret Foti stands at podium
Margaret Foti, Ph.D., M.D. (hc), CEO of the American Association for Cancer Research, spoke at the 2024 RAS Initiative Symposium, saying it is a “transformational era in cancer research, with greater translation of basic science to the clinic,” that will extend to the other KRAS-driven cancer types, including pancreatic and colorectal cancers.
Scientists engaging with a poster presentation
Poster presentation from the 2022 RAS Initiative Symposium.
View from above of people sitting together outside
Attendees enjoying lunch and networking outside.
Two scientists pose for the camera in an auditorium
NCI Director W. Kimryn Rathmell (right), with University of Toronto's Meredith Irwin, gave opening remarks at the 2024 RAS Initiative Symposium.
Three scientists stand together facing the camera at the 2022 RAS Initiative Symposium
Attendees during one of the poster presentations. From left: Ethan Dmitrovsky, M.D., director of the Frederick National Laboratory for Cancer Research, Felice Lightstone, Ph.D., Biochemical and Biophysical Systems Group leader, Lawrence Livermore National Laboratory, and Dwight Nissley, Ph.D., director of the Cancer Research and Technology Program and RAS Initiative leader, Frederick National Laboratory.
Audience in an auditorium for the 2017 RAS Initiative Symposium
Attendees gather for opening remarks in the auditorium at the 2017 RAS Initiative Symposium.
Five scientists seated at a table in front of a presentation.
A panel discussion during the 2022 RAS Initiative Symposium.
Frank McCormick speaking at the 2017 RAS Initiative Symposium
Frank McCormick, Ph.D., RAS National Program advisor and professor at UCSF Helen Diller Family Comprehensive Cancer Center speaking during the 2017 RAS Initiative Symposium.